Delivery Order SPE2DB25D3504-SPE2DB25FVURF

Award Date 5/12/25
Potential Completion Date 5/13/25
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Descovy 200-25 mg tablets, a medication used to treat HIV, with a ceiling value of $9,519.88 and a period of performance through May 1, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Descovy 200-25 mg tablets, a medication used to treat HIV/AIDS. The contract has a ceiling value of $19,547.98 and a completion date of May 23, 2024. It is a firm-fixed-price contract, meaning the price does not change regardless of the contractor's actual costs. The contract is not designated as a set-aside,...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Descovy 200-25 mg tablets, a medication used to treat HIV. The contract has a ceiling value of $5,934.16 and a performance period ending on May 15, 2025. This contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Descovy 200-25 mg tablets, a medication used for the treatment of HIV. The contract has a ceiling value of $11,258.37 and runs through October 16, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Descovy 200-25 mg tablets, a medication used to treat HIV. The contract has a total ceiling value of $41,991.64 and a performance period ending on April 30, 2025. The contract is a firm-fixed-price delivery order, which indicates that the price for the goods is set and will not...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,287.62 firm-fixed-price contract is for the supply of Descovy 200-25 mg tablets, which are likely used to treat medical conditions such as HIV. The contract has an ultimate completion date of May 15, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $20,889.61, is for the delivery of Descovy 200-25 mg tablets, a medication used to treat HIV infection. The contract has a firm fixed price and an ultimate completion date of January 31, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corporation, the prime contractor, is a for-profit...
This federal contract award, valued at $43,879.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Descovy 200-25 mg tablet medication, a prescription drug used to treat HIV infection. This is a firm fixed-price delivery order contract with a completion date of May 12, 2025. The award is not designated as a set-aside contract, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,936.48, is for the delivery of Descovy 200-25 mg tablets, a medication used in the treatment of HIV. The contract is a firm fixed-price delivery order with a period of performance through November 1, 2023. This award is part of a larger Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Descovy 200-25 mg tablets, a prescription medication, with a ceiling value of $18,417.91. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any major subcontractors. The...
  • SPE2DB25D3504
    Indefinite Delivery Contract
  • SPE2DB25D3504-SPE2DB25FVURF
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Descovy 200-25 mg tablet, a medication used to treat HIV. The contract has a firm fixed price, with a ceiling value of $4,243.88, and a completion date of May 13, 2025. The contract is not set aside and is open to full and open competition.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This allows AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/17/25, 1:18 AM